Page last updated: 2024-10-24

cefuroxime and Lupus Erythematosus, Cutaneous, Subacute

cefuroxime has been researched along with Lupus Erythematosus, Cutaneous, Subacute in 1 studies

Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rudnicka, L1
Szymańska, E1
Walecka, I1
Słowińska, M1

Other Studies

1 other study available for cefuroxime and Lupus Erythematosus, Cutaneous, Subacute

ArticleYear
Long-term cefuroxime axetil in subacute cutaneous lupus erythematosus. A report of three cases.
    Dermatology (Basel, Switzerland), 2000, Volume: 200, Issue:2

    Topics: Adult; Cefuroxime; Cephalosporins; Female; Humans; Lupus Erythematosus, Cutaneous; Middle Aged; Skin

2000